Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:36 PM
Ignite Modification Date:
2025-12-24 @ 9:36 PM
NCT ID:
NCT04283032
Eligibility Criteria:
Inclusion Criteria:
* Signature of informed consent prior to performing any of the specific procedures of the study
* Age between 50 \* - 75 years (\* 45 years, if family history)
* Patients with clinical suspicion of prostate cancer
* Indication of a first biopsy during the study period.
* Life expectancy greater than 10 years.
Exclusion Criteria:
* Patients previously randomized in the present study.
* Patients submitted prior to a prostate biopsy.
* Patients with a previous diagnosis of prostate cancer and / or previous prostate surgery.
* Patients with a previous episode of acute prostatitis of infectious origin in the 3 months prior to inclusion in the study.
* Patients with an active urinary tract infection and / or any previous pathology of severity in the 3 months prior to inclusion.
* Impossibility of performing transrectal or transperineal biopsy and / or magnetic resonance.
* Patients who have received hormonal treatment prior to androgen blockade in the 6 months prior to inclusion in the study.
* History of other tumors.
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
45 Years
Maximum Age:
75 Years
Study:
NCT04283032
Study Brief:
Protocol Section:
NCT04283032